ZITUVIO
NDC 70710-1240, Sitagliptin, tablet, from Zydus Pharmaceuticals (USA) Inc..
- Product NDC
- 70710-1240
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211566
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1240 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SITAGLIPTIN25 mg/1
Pharmacologic classes
Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1240-3 | 70710124003 | 30 TABLET in 1 BOTTLE (70710-1240-3) |
| 70710-1240-9 | 70710124009 | 90 TABLET in 1 BOTTLE (70710-1240-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/abfdea45-c0ca-41e3-a510-e89810bc9cfeNADAC price for package 70710124003
GET /v1/drugs/nadac/70710124003
Use it
Look up 70710-1240 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1240 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1240. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.